NO137899C - Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider

Info

Publication number
NO137899C
NO137899C NO2705/73A NO270573A NO137899C NO 137899 C NO137899 C NO 137899C NO 2705/73 A NO2705/73 A NO 2705/73A NO 270573 A NO270573 A NO 270573A NO 137899 C NO137899 C NO 137899C
Authority
NO
Norway
Prior art keywords
damides
kinal
tetrazol
preparation
therapeutic active
Prior art date
Application number
NO2705/73A
Other languages
English (en)
Other versions
NO137899B (no
Inventor
David Edmund Bays
Mervyn Evan Peel
David Martin Waters
Gwynn Pennant Ellis
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of NO137899B publication Critical patent/NO137899B/no
Publication of NO137899C publication Critical patent/NO137899C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
NO2705/73A 1972-07-03 1973-07-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider NO137899C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3099072A GB1383088A (en) 1972-07-03 1972-07-03 Pharmacologically active quinaldamide derivatives

Publications (2)

Publication Number Publication Date
NO137899B NO137899B (no) 1978-02-06
NO137899C true NO137899C (no) 1978-05-16

Family

ID=10316264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2705/73A NO137899C (no) 1972-07-03 1973-07-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider

Country Status (20)

Country Link
US (1) US3932416A (no)
JP (1) JPS4962486A (no)
AT (1) AT328449B (no)
AU (1) AU473752B2 (no)
BE (1) BE801246A (no)
CH (1) CH592081A5 (no)
CS (1) CS193474B2 (no)
DE (1) DE2332731A1 (no)
ES (1) ES416495A1 (no)
FR (1) FR2247241B1 (no)
GB (1) GB1383088A (no)
HU (1) HU168474B (no)
IE (1) IE37795B1 (no)
IL (1) IL42513A (no)
LU (1) LU67918A1 (no)
NL (1) NL7309226A (no)
NO (1) NO137899C (no)
PH (1) PH9997A (no)
SE (1) SE405477B (no)
ZA (1) ZA734041B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4156726A (en) * 1974-12-07 1979-05-29 Fisons Limited 4-Oxo-2-carboxyl quinoline derivatives used as antiallergic compounds
US4186201A (en) * 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4147694A (en) * 1977-02-07 1979-04-03 Riker Laboratories, Inc. 8-(1H-Tetrazol-5-yl-carbamoyl)quinoline compounds
US4474792A (en) * 1979-06-18 1984-10-02 Riker Laboratories, Inc. N-Tetrazolyl benzamides and anti-allergic use thereof
EP0035412A1 (en) * 1980-03-05 1981-09-09 Glaxo Group Limited Amidotetrazole compounds and processes for their preparation
JPS61197558A (ja) * 1985-02-25 1986-09-01 Nippon Chemiphar Co Ltd 新規なキナルジン酸アミド誘導体およびその製造法
US4772703A (en) * 1986-01-27 1988-09-20 American Home Products Corporation 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents
EP0412848B1 (en) * 1989-08-11 1995-01-18 Zeneca Limited Quinoline derivatives, process for their preparation and their use as medicaments
US5028707A (en) * 1989-11-20 1991-07-02 Board Of Regents, University Of Texas 4-hydroxyquinaldic acid derivatives
GB9010394D0 (en) * 1990-05-09 1990-06-27 Ici Plc Heterocyclic compounds
EP0975621A1 (en) * 1997-04-25 2000-02-02 Takeda Chemical Industries, Ltd. Cell differentiation inducing amide derivatives, their production and use
WO2001012608A1 (fr) * 1999-08-18 2001-02-22 Nippon Soda Co., Ltd. Composes de quinoline et procede de preparation desdits composes
FR2827599A1 (fr) * 2001-07-20 2003-01-24 Neuro3D Composes derives de quinoleine et quinoxaline,preparation et utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3391146A (en) * 1964-11-10 1968-07-02 Bristol Myers Co Nu-substituted carbamates and thiocarbamates of 2-quinolinemethanols

Also Published As

Publication number Publication date
ZA734041B (en) 1974-05-29
IL42513A0 (en) 1973-08-29
LU67918A1 (no) 1973-09-05
IE37795L (en) 1974-01-03
NO137899B (no) 1978-02-06
BE801246A (fr) 1973-12-21
CS193474B2 (en) 1979-10-31
AT328449B (de) 1976-03-25
FR2247241A1 (no) 1975-05-09
GB1383088A (en) 1975-02-05
PH9997A (en) 1976-07-13
HU168474B (no) 1976-05-28
IL42513A (en) 1976-12-31
NL7309226A (no) 1974-01-07
IE37795B1 (en) 1977-10-12
SE405477B (sv) 1978-12-11
FR2247241B1 (no) 1976-12-31
ES416495A1 (es) 1976-06-01
CH592081A5 (no) 1977-10-14
DE2332731A1 (de) 1974-03-07
ATA570873A (de) 1975-06-15
AU473752B2 (en) 1976-07-01
AU5709973A (en) 1974-12-19
US3932416A (en) 1976-01-13
JPS4962486A (no) 1974-06-17

Similar Documents

Publication Publication Date Title
NO138807C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO793013L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO137824C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkyltetrazoler
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer